Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 21

Trial Status

Completed2

Role Distribution

Other Roles2

Activity Timeline

Clinical Trials (2)

NCT02327078Phase 1/2Completed
A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)
B-cell MalignanciesColorectal Cancer (CRC)Glioblastoma+5 more
StudydirectorStart date: 2014-11-26
NCT01072266Phase 1Completed
A Dose-escalation Study in Subjects With Advanced Malignancies
Advanced CancerMetastatic CancerSolid Tumor
Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

MelanomaMetastatic CancerOvary Cancer+2 more
Similarity Score14%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

GlioblastomaCancer of Head and NeckLung Cancer+2 more
Similarity Score14%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Lung CancerCancer of Head and NeckOvary Cancer+1 more
Similarity Score11%

Hagop Youssoufian, MD

Verastem, Inc.

Related
20 trials

Shared therapeutic areas:

LymphomaMetastatic CancerOvary Cancer
Similarity Score8%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Lung CancerCancer of Head and NeckOvary Cancer

Worked with same sponsors:

Bristol-Myers SquibbNovartis Pharmaceuticals
Similarity Score8%

Aminah Jatoi, MD

Mayo Clinic

Related
29 trials

Shared therapeutic areas:

Lung CancerCancer of Head and NeckMetastatic Cancer
Similarity Score8%

Lin Shen, MD

Peking University Cancer Hospital & Institute

Related
20 trials

Shared therapeutic areas:

Solid TumorAdvanced CancerLung Cancer
Similarity Score8%

Mark Levine, MD

Ontario Clinical Oncology Group (OCOG)

Related
13 trials

Shared therapeutic areas:

Cancer of Head and NeckLymphomaOvary Cancer

Worked with same sponsors:

Novartis Pharmaceuticals
Similarity Score8%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Advanced CancerLymphoma
Similarity Score5%

You Lu, MD

West China Hospital

Related
18 trials

Shared therapeutic areas:

Lung CancerSolid Tumor
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT02327078Phase 1/2StudyDirector

A Study of the Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

B-cell MalignanciesColorectal Cancer (CRC)Glioblastoma+5 more
Completed
NCT01072266Phase 1StudyDirector

A Dose-escalation Study in Subjects With Advanced Malignancies

Advanced CancerMetastatic CancerSolid Tumor
Completed

All 2 trials loaded